Articles
AES Clean Technology Post-COVID Supply Chain Commentary
OCT 2021 At AES Clean Technology, we had front-row seats to many of the challenges and triumphs created by the pandemic. There were several factors affecting the supply chain that changed the way we did business, which included direct...
Articles
INCOG: Supply chain commentary
Tedd Green, COO at INCOG Biopharma Services discusses the supply chain challenges that pharmaceutical companies have faced due to the COVID-19 pandemic and what the future of the pharma supply chain looks like.
From shortly after the onset of...
Articles
ChargePoint Technology: Post-COVID Supply Chain Commentary
The pharmaceutical industry and its supply chain have both undergone considerable upheaval due to the COVID-19 pandemic. The closure of factories in Asia producing the bulk of the world’s supply of active pharmaceutical ingredients (APIs) during the first lockdown...
Articles
A Strong Partnership in Drug Development – How CDMOs and Consultants Mutually Benefit Their Clients
The field of drug development can be risky and a costly investment - mistakes can mean the success or failure of a compound or even a company. And, while demands for specialized treatments and therapies continues to surge around...
Articles
What is the Internet of Behaviours (IoB) and why Pharma and Health Brands should be paying attention
The Internet of Things (IoT) has been the topic of discussion for many years in the technology and data circles. However, the Internet cannot exist without people and what they do with it. This has led to a line...
Articles
A key decision in sterile manufacturing: Choosing the right CDMO partner
Contamination of drug substances and drug products leads to a risk of harm. This risk is particularly high in drugs delivered via the intravenous or ophthalmic routes, as these drugs bypass many of the body’s natural defenses. The development...
Articles
How innovation and responsibility contribute to patient’s well-being
In the health care industry, changes are occurring at a rapid pace. People, machines, and information are becoming even more interconnected. Meanwhile, unanticipated events such as the Covid-19 pandemic affect the pharma and biotech industry as well. To meet...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.